The U.S. FDA announced that has delayed the much anticipated decision on Hemispherx Biopharma Inc.’s drug Ampligen (poly I: poly C12U) for chronic fatigue syndrome. The decision was due February 25, but now the FDA say it needs another 3 months in order to review all of the data.
http://chronicfatigue.about.com/b/2009/02/25/fda-delays-decision-on-ampligen-for-chronic-fatigue-syndrome.htm
The administrators of the ‘Living With ME’ website do not advocate the use of any particular type of medication, treatment or healthcare! YOU should ALWAYS seek advice from a DOCTOR / GP / CONSULTANT before undertaking or ceasing any treatment!
This entry was posted
on Friday, February 27th, 2009 at 10:00 am and is filed under ME News & Views.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.